Differential expression of specific FGF ligands and receptor isoforms during osteogenic differentiation of mouse Adipose-derived Stem Cells (mASCs) recapitulates the in vivo osteogenic pattern

Gene

Volumn 424, Issue 1-2, 2008, Pages 130-140

  Quarto, Natalina ^a,b   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Adipose derived stem cell; FGF ligands; FGFRs; HMWFGF 2; Osteogenesis; Translation

Indexed keywords

FIBROBLAST GROWTH FACTOR 18; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2;

ADIPOSE TISSUE CELL; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; IN VIVO STUDY; MALE; MESENCHYME CELL; MOLECULAR WEIGHT; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADIPOSE TISSUE; ALKALINE PHOSPHATASE; ANIMALS; DNA PRIMERS; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; KINETICS; MALE; MICE; MICE, INBRED STRAINS; MOLECULAR WEIGHT; OSTEOGENESIS; RECEPTORS, FIBROBLAST GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STEM CELLS;

EID: 53149119884     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2008.07.029     Document Type: Article

References (81)

1. Boulet A.M., Moon A.M., Arenkiel B.R., and Capecchi M.R. The roles of Fgf4 and Fgf8 in limb bud initiation and outgrowth. Dev. Biol. 273 (2004) 361-372
2. Bugler B., Amalric F., and Prats H. Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol. Cell. Biol. 11 (1991) 573-577
3. Burke D., Wilkes D., Blundell T.L., and Malcolm S. Fibroblast growth factor receptors: lessons from the genes. Trends Biochem. Sci. 23 (1998) 59-62
4. Canalis E., Centrella M., and McCarthy T. Effects of basic fibroblast growth factor on bone formation in vitro. J. Clin. Invest. 81 (1988) 1572-1577
5. Chaudhary L.R., Hofmeister A.M., and Hruska K.A. Differential growth factor control of bone formation through osteoprogenitor differentiation. Bone 34 (2004) 402-411
6. Coffin J.D., et al. Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol. Biol. Cell. 6 (1995) 1861-1873
7. Cowan C.M., Quarto N., Warren S.M., Salim A., and Longaker M.T. Age-related changes in the biomolecular mechanisms of calvarial osteoblast biology affect fibroblast growth factor-2 signaling and osteogenesis. J. Biol. Chem. 278 (2003) 32005-32013
8. Cowan C.M., et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat. Biotechnol. 22 (2004) 560-567
9. De Ugarte D.A., et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174 (2003) 101-109
10. Delrieu I. The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): an insight into an intracrine mechanism. FEBS Lett. 468 (2000) 6-10
11. Deng C., Wynshaw-Boris A., Zhou F., Kuo A., and Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84 (1996) 911-921
12. Derubeis A.R., and Cancedda R. Bone marrow stromal cells (BMSCs) in bone engineering: limitations and recent advances. Ann. Biomed. Eng. 32 (2004) 160-165
13. Dono R., James D., and Zeller R. A GR-motif functions in nuclear accumulation of the large FGF-2 isoforms and interferes with mitogenic signalling. Oncogene 16 (1998) 2151-2158
14. Draper B.W., Stock D.W., and Kimmel C.B. Zebrafish fgf24 functions with fgf8 to promote posterior mesodermal development. Development 130 (2003) 4639-4654
15. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
16. Erickson G.R., Gimble J.M., Franklin D.M., Rice H.E., Awad H., and Guilak F. Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem. Biophys. Res. Commun. 290 (2002) 763-769
17. Eswarakumar V.P., Monsonego-Ornan E., Pines M., Antonopoulou I., Morriss-Kay G.M., and Lonai P. The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129 (2002) 3783-3793
18. Fakhry A., et al. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Bone 36 (2005) 254-266
19. Florkiewicz R.Z., and Sommer A. Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 3978-3981
20. Franceschi R.T. Biological approaches to bone regeneration by gene therapy. J. Dent. Res. 84 (2005) 1093-1103
21. Funato N., Ohtani K., Ohyama K., Kuroda T., and Nakamura M. Common regulation of growth arrest and differentiation of osteoblasts by helix-loop-helix factors. Mol. Cell. Biol. 21 (2001) 7416-7428
22. Gimble J.M., and Guilak F. Differentiation potential of adipose derived adult stem (ADAS) cells. Curr. Top. Dev. Biol. 58 (2003) 137-160
23. Gimble J.M., Katz A.J., and Bunnell B.A. Adipose-derived stem cells for regenerative medicine. Circ. Res. 100 (2007) 1249-1260
24. Govindarajan V., and Overbeek P.A. FGF9 can induce endochondral ossification in cranial mesenchyme. BMC Dev. Biol. 6 (2006) 7
25. Gregory C.A., Prockop D.J., and Spees J.L. Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation. Exp. Cell. Res. 306 (2005) 330-335
26. Hajihosseini M.K., and Heath J.K. Expression patterns of fibroblast growth factors-18 and -20 in mouse embryos is suggestive of novel roles in calvarial and limb development. Mech. Dev. 113 (2002) 79-83
27. Halvorsen Y.D., et al. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng. 7 (2001) 729-741
28. Haynesworth S.E., Goshima J., Goldberg V.M., and Caplan A.I. Characterization of cells with osteogenic potential from human marrow. Bone 13 (1992) 81-88
29. Hung I.H., Yu K., Lavine K.J., and Ornitz D.M. FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod. Dev. Biol. 307 (2007) 300-313
30. Iseki S., Wilkie A.O., and Morriss-Kay G.M. Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development 126 (1999) 5611-5620
31. Itoh N., and Ornitz D.M. Functional evolutionary history of the mouse Fgf gene family. Dev. Dyn. 237 (2008) 18-27
32. Johnson D.E., and Williams L.T. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60 (1993) 1-41
33. Karsenty G. Minireview: transcriptional control of osteoblast differentiation. Endocrinology 142 (2001) 2731-2733
34. Karsenty G., and Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell. 2 (2002) 389-406
35. Kawaguchi H., et al. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 135 (1994) 774-781
36. Komori T., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
37. Liu Z., Xu J., Colvin J.S., and Ornitz D.M. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev. 16 (2002) 859-869
38. Mansukhani A., Bellosta P., Sahni M., and Basilico C. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J. Cell. Biol. 149 (2000) 1297-1308
39. Marie P.J. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 316 (2003) 23-32
40. Mayahara H., et al. In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors 9 (1993) 73-80
41. Mignatti P., Morimoto T., and Rifkin D.B. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J. Cell. Physiol. 151 (1992) 81-93
42. Molteni A., Modrowski D., Hott M., and Marie P.J. Differential expression of fibroblast growth factor receptor-1, -2, and -3 and syndecan-1, -2, and -4 in neonatal rat mandibular condyle and calvaria during osteogenic differentiation in vitro. Bone 24 (1999) 337-347
43. Montero A., et al. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J. Clin. Invest. 105 (2000) 1085-1093
44. Muenke M., and Schell U. Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet. 11 (1995) 308-313
45. Murakami S., Balmes G., McKinney S., Zhang Z., Givol D., and de Crombrugghe B. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes Dev. 18 (2004) 290-305
46. Nakamura T., et al. Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture. J. Bone Miner. Res. 13 (1998) 942-949
47. Naski M.C., and Ornitz D.M. FGF signaling in skeletal development. Front. Biosci. 3 (1998) d781-d794
48. Ohbayashi N., Shibayama M., Kurotaki Y., Imanishi M., Fujimori T., Itoh N., and Takada S. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 16 (2002) 870-879
49. Ornitz D.M., and Itoh N. Fibroblast growth factors. Genome Biol. 2 (2001) REVIEWS3005
50. Ornitz D.M., and Marie P.J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 16 (2002) 1446-1465
51. Pintucci G., Quarto N., and Rifkin D.B. Methylation of high molecular weight fibroblast growth factor-2 determines post-translational increases in molecular weight and affects its intracellular distribution. Mol. Biol. Cell. 7 (1996) 1249-1258
52. Pintucci G., Yu P.J., Saponara F., Kadian-Dodov D.L., Galloway A.C., and Mignatti P. PDGF-BB induces vascular smooth muscle cell expression of high molecular weight FGF-2, which accumulates in the nucleus. J. Cell. Biochem. 95 (2005) 1292-1300
53. Pittenger M.F., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
54. Prats H., et al. High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 1836-1840
55. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 (1997) 71-74
56. Quarto N., and Longaker M.T. FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng. 12 (2006) 1405-1418
57. Quarto N., Finger F.P., and Rifkin D.B. The NH2-terminal extension of high molecular weight bFGF is a nuclear targeting signal. J. Cell. Physiol. 147 (1991) 311-318
58. Quarto N., Talarico D., Florkiewicz R., and Rifkin D.B. Selective expression of high molecular weight basic fibroblast growth factor confers a unique phenotype to NIH 3T3 cells. Cell. Regul. 2 (1991) 699-708
59. Quarto N., Fong K.D., and Longaker M.T. Gene profiling of cells expressing different FGF-2 forms. Gene 356 (2005) 49-68
60. Quarto N., WD, and Longaker M.T. Molecular mechanisms of FGF-2 inhibitory activity in the osteogenic context of mouse adipose-derived stem cells (mASCs). Bone 42 (2008) 1040-1052
61. Radomsky M.L., Thompson A.Y., Spiro R.C., and Poser J.W. Potential role of fibroblast growth factor in enhancement of fracture healing. Clin. Orthop. Relat. Res. (1998) S283-S293
62. Renko M., Quarto N., Morimoto T., and Rifkin D.B. Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J. Cell. Physiol. 144 (1990) 108-114
63. Rice D.P., et al. Integration of FGF and TWIST in calvarial bone and suture development. Development 127 (2000) 1845-1855
64. Rice D.P., Rice R., and Thesleff I. Fgfr mRNA isoforms in craniofacial bone development. Bone 33 (2003) 14-27
65. Riese J., Zeller R., and Dono R. Nucleo-cytoplasmic translocation and secretion of fibroblast growth factor-2 during avian gastrulation. Mech. Dev. 49 (1995) 13-22
66. Rodan S.B., Wesolowski G., Yoon K., and Rodan G.A. Opposing effects of fibroblast growth factor and pertussis toxin on alkaline phosphatase, osteopontin, osteocalcin, and type I collagen mRNA levels in ROS 17/2.8 cells. J. Biol. Chem. 264 (1989) 19934-19941
67. Sakano S., et al. Inhibitory effect of bFGF on endochondral heterotopic ossification. Biochem. Biophys. Res. Commun. 293 (2002) 680-685
68. Shimoaka T., et al. Regulation of osteoblast, chondrocyte, and osteoclast functions by fibroblast growth factor (FGF)-18 in comparison with FGF-2 and FGF-10. J. Biol. Chem. 277 (2002) 7493-7500
69. Sorensen V., Nilsen T., and Wiedlocha A. Functional diversity of FGF-2 isoforms by intracellular sorting. Bioessays 28 (2006) 504-514
70. Sun X., Lewandoski M., Meyers E.N., Liu Y.H., Maxson Jr. R.E., and Martin G.R. Conditional inactivation of Fgf4 reveals complexity of signalling during limb bud development. Nat. Genet. 25 (2000) 83-86
71. Vagner S., et al. Translation of CUG- but not AUG-initiated forms of human fibroblast growth factor 2 is activated in transformed and stressed cells. J. Cell. Biol. 135 (1996) 1391-1402
72. Valta M.P., et al. Regulation of osteoblast differentiation: a novel function for fibroblast growth factor 8. Endocrinology 147 (2006) 2171-2182
73. Wan D.C., Shi Y.Y., Nacamuli R.P., Quarto N., Lyons K.M., and Longaker M.T. Osteogenic differentiation of mouse adipose-derived adult stromal cells requires retinoic acid and bone morphogenetic protein receptor type IB signaling. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 12335-12340
74. Wilkie A.O., Morriss-Kay G.M., Jones E.Y., and Heath J.K. Functions of fibroblast growth factors and their receptors. Curr. Biol. 5 (1995) 500-507
75. Wilkie A.O., et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat. Genet. 9 (1995) 165-172
76. Yamaguchi T.P., and Rossant J. Fibroblast growth factors in mammalian development. Curr. Opin. Genet. Dev. 5 (1995) 485-491
77. Yu K., et al. Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130 (2003) 3063-3074
78. Yu P.J., Ferrari G., Galloway A.C., Mignatti P., and Pintucci G. Basic fibroblast growth factor (FGF-2): the high molecular weight forms come of age. J. Cell. Biochem. 100 (2007) 1100-1108
79. Zhou Y.X., Xu X., Chen L., Li C., Brodie S.G., and Deng C.X. A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum. Mol. Genet. 9 (2000) 2001-2018
80. Zuk P.A., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7 (2001) 211-228
81. Zuk P.A., et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell. 13 (2002) 4279-4295